Skip to main content
. 2019 Apr 26;10:856. doi: 10.3389/fmicb.2019.00856

FIGURE 1.

FIGURE 1

Recombinant vesiculoviruses used in this study. (A) Genome schematic of rVSIV expressing its native G and eGFP (rVSIV–VSIV G control; top row) and rVSIVs created for this study encoding tibrovirus G instead of VSIV G (other rows). (B) Infectivity of rVSIV–VSIV G control (MOI = 3). The percentage of eGFP-expressing NCI-60 human cell panel cell lines was measured by high-content imaging at 24 h post-exposure (“negatives” were confirmed also at 72 h post-exposure, not shown). All experiments were performed in triplicate; error bars show standard deviations. BHV, Beatrice Hill virus; BASV, Bas-Congo virus; BAV, Bivens Arm virus; CNS, central nervous system, CPV; Coastal Plains virus; EKV-1, Ekpoma virus 1; EKV-2, Ekpoma virus 2; MOI, multiplicity of infection; NCI, National Cancer Institute; SWBV, Sweetwater Branch virus; TIBV, Tibrogargan virus. NCI-60 cell lines are listed by their abbreviations and grouped by organ/cancer type.